Vitadi 3 Nex Injection (Cholecalciferol)

Adult administration

Administer 200,000 IU as an intramuscular injection of cholecalciferol. For the elderly, administer 100,000 IU as an intramuscular injection of cholecalciferol. Ensure the annual dosage does not exceed 600,000 IU as cholecalciferol.

Child administration

Administer 200,000 IU as an intramuscular injection of cholecalciferol.

This drug is an injectable form of vitamin D, and to avoid overdose, the total vitamin D content should be confirmed when taken with other therapies or fortified foods containing vitamin D. Routine testing of calcium levels in the blood and urine should be performed, and administration should be discontinued if levels exceed the normal range. Particularly for patients with high calcium intake, it is important to regularly monitor calcium levels in the blood and urine. Care must be taken to avoid glass particles when cutting the ampoule, and extra caution is needed when using it for children or the elderly. This drug should not be administered to patients with certain conditions or diseases, such as those with hypercalcemia, renal dysfunction, or pregnant or breastfeeding women should avoid its use. Various side effects may occur, such as headache, fatigue, muscle pain, gastrointestinal disturbances, dehydration, increased blood pressure, and kidney problems, so immediate consultation with medical personnel is necessary if any abnormal symptoms arise. Regular monitoring of vitamin D levels in the blood and parathyroid hormone levels is important to maintain an appropriate dosage. Patients with impaired kidney function or those taking certain concomitant medications should be more diligent in checking kidney function and calcium levels, and dosage adjustments or discontinuation may be required. This drug may interact with other medications, so if there are other medications being taken, it is crucial to inform the healthcare provider. It should not be used during pregnancy, and the use in children under 12 years is not recommended as safety and efficacy have not been established. In case of overdose, immediately stop administration, reduce calcium intake, increase diuresis, and increase fluid intake. Do not mix this drug with other medications, use it quickly after opening, and dispose of any remaining medication appropriately. When storing, keep it in a light-blocking container and maintain a storage temperature between 1°C and 25°C to preserve its efficacy.

Serious side effects

Hives, severe swelling (edema), hypertension and severe edema due to hypercalcemia, kidney dysfunction, arrhythmias, severe allergic reactions, severe skin adverse reactions, respiratory issues, liver dysfunction (jaundice), serious neurological symptoms, urinary abnormalities

Mild side effects

Headache, weakness, fatigue, muscle pain, loss of appetite, weight loss, growth retardation, nausea, vomiting, constipation, diarrhea, polydipsia, polyuria, dehydration, hypertension, calcium stones, tissue calcification in the kidneys and blood vessels, kidney dysfunction, excessive bone calcification, arrhythmia, psychological symptoms, perceptual disturbances, joint pain, myasthenia, drowsiness, azotemia, hypersensitivity reactions, thirst, confusion, bloating, abdominal pain, metallic taste, dry mouth, rash, itching, hypercalciuria,

This drug should be stored in a container that can block light, and the storage temperature should be maintained between 1°C and 25°C. This will help maintain the drug's efficacy over time.

Appearance

A light yellow transparent liquid in a brown glass ampoule

Package unit

10 ampoules/box [1.5 mL/ampoule], 10 ampoules/box [1 mL/ampoule]